Back
Biomarin Pharmaceutical Stock Predictions
Sponsored
BMRN
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64
BMRN
Biomarin Pharmaceutical
Last Price:
64.87
Seasonality Move:
8.34%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Biomarin Pharmaceutical Stock Forecast
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.1% based on the past 25 years of stock performance.
- Biomarin Pharmaceutical has risen higher in 14 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 56%
-
Is Biomarin Pharmaceutical Stock Undervalued?
The current Biomarin Pharmaceutical [BMRN] share price is $65.09. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal. - BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.1% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Buy
64
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical overpriced?
- Biomarin Pharmaceutical has risen higher in 14 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 56%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
99.56
52-Week Low:
61.15
Prediction Charts
Market Cap:
12.41B
Price in USD:
65.09
Volume:
2.08M
Beta:
0.88
Technical Analysis
SMA50:
68.16
SMA100:
77.40
SMA200:
80.94
52-Wk Change:
-26.19%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?
Yes, Biomarin Pharmaceutical is a publicly traded company. -
What is the Biomarin Pharmaceutical stock quote today?
The Biomarin Pharmaceutical stock price is 65.09 USD today. -
How to buy Biomarin Pharmaceutical stock online?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-6 | 67.31 | 66.14 | 67.64 | 65.79 |
Nov-7 | 66.32 | 66.94 | 67.30 | 65.76 |
Nov-8 | 66.76 | 67.07 | 67.44 | 66.67 |
Nov-11 | 67.21 | 66.36 | 67.95 | 66.33 |
Nov-12 | 65.96 | 66.12 | 66.69 | 65.80 |
Nov-13 | 66.18 | 66.66 | 67.00 | 66.00 |
Nov-14 | 66.37 | 65.60 | 67.00 | 65.53 |
Nov-15 | 66.05 | 63.42 | 66.05 | 63.22 |
Nov-18 | 63.15 | 61.93 | 63.52 | 61.40 |
Nov-19 | 61.57 | 61.97 | 62.03 | 61.15 |
Nov-20 | 61.97 | 62.56 | 62.70 | 61.61 |
Nov-21 | 62.40 | 63.45 | 63.76 | 61.41 |
Nov-22 | 63.88 | 64.26 | 64.46 | 63.78 |
Nov-25 | 64.35 | 65.09 | 65.69 | 64.32 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.